---
layout: post
title: USAN Watch - March 2013
date: '2013-03-13T13:29:00.003Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-03-17T20:33:17.605Z'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-2443528930533729308
blogger_orig_url: http://chembl.blogspot.com/2013/03/usan-watch-march-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for March 2013 have recently been published.</span><br />
<br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b>InChIKey (Parent)</b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/avarofloxacin-hydrochloride.pdf">avarofloxacin hydrochloride </a></td><td>JNJ-32729463 </td><td>UAJMNUKJPPPJJT-CLNHMMGSSA-N</td><td>synthetic small molecule </td><td>therapeutic </td><td>topo II</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lubabegron.pdf">lubabegron</a>, <a href="http://www.ama-assn.org/resources/doc/usan/lubabegron-fumarate.pdf">lubabegron fumarate </a></td><td>LY-488756 </td><td>WIKLBKJBYSBYLL-QHCPKHFHSA-N</td><td>synthetic small molecule </td><td>therapeutic </td><td>beta 3 receptor</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/methylsamidorphan-chloride.pdf">methylsamidorphan chloride </a></td><td>RDC-1036-03 </td><td></td><td>natural product-derived small molecule </td><td>therapeutic </td><td>opioid receptors</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/palbociclib-isethionate.pdf">palbociclib isethionate </a></td><td>PD-332991, PF-00080665 </td><td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td><td>synthetic small molecule </td><td>therapeutic </td><td>CDK4 CDK6</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pevonedistat-hcl.pdf">pevonedistat hydrochloride </a></td><td>MLN-4924 </td><td>UPOLJMQMGITQAT-MNDZRTMASA-N</td><td>synthetic small molecule </td><td>therapeutic </td><td>NAE</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/rivipansel-sodium.pdf">rivipansel sodium </a></td><td>GMI-1070, PF-06460031 </td><td></td><td>natural product-derived small molecule </td><td>therapeutic </td><td>selectins</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/sarecycline.pdf">sarecycline</a>, <a href="http://www.ama-assn.org/resources/doc/usan/sarecycline-hydrochloride.pdf">sarecycline hydrochloride </a></td><td>P-005672 </td><td>APPRLAGZQKOUFL-UHFFFAOYSA-N</td><td>natural product derived small molecule </td><td>therapeutic </td><td>30S ribosome</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/tenofovir-alafenamide-fumarate.pdf">tenofovir alafenamide fumarate </a></td><td>GS-7340 </td><td>LDEKQSIMHVQZJK-CAQYMETFSA-N</td><td>synthetic small molecule </td><td>therapeutic prodrug</td><td>HIV RT</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/velcalcetide.pdf">velcalcetide </a></td><td>KAI-4169 </td><td>C.dCdAdRdRdRdAdR</td><td>peptide </td><td>therapeutic</td><td>CaSr</td></tr>
</tbody></table>
